# Lubiprostone for Functional Constipation in the Under 18 Years Patients

> **NCT05144295** · PHASE3 · COMPLETED · sponsor: **Alexandria University** · enrollment: 274 (actual)

## Conditions studied

- Clinical Efficacy
- Treatment Efficacy
- Drug Side Effect

## Interventions

- **DRUG:** Lubiprostone Pill
- **DRUG:** Lactulose Oral Liquid Product
- **DRUG:** Bisacodyl 5 MG
- **DRUG:** Sodium Picosulfate

## Key facts

- **NCT ID:** NCT05144295
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-11-01
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144295, "Lubiprostone for Functional Constipation in the Under 18 Years Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05144295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*